معرفی
Matthias Hebrok is a Professor at the University of California San Francisco, focusing on pancreatic biology and disease. His research investigates the roles of embryonic signaling pathways in pancreas development, diabetes, and pancreatic ductal adenocarcinoma (PDA). He has pioneered studies on cell dedifferentiation in pancreatic neoplasia and beta cell stress in diabetes pathogenesis.
Dr. Hebrok holds multiple NIH grants, including R01DK090570 and UH3DK120004, as Principal Investigator. His work spans molecular mechanisms of beta cell identity, epigenetic regulation in pancreatic cancer, and innovative cell encapsulation technologies for diabetes therapy.
- 1994 Graduate Student Research Award, Hoechst AG
- Howard Hughes Medical Institute Postdoctoral Fellowship, 1997-1999
- Sandler Program in Basic Sciences Junior Faculty Start-up Award, 2000
- Career Development Award, Juvenile Diabetes Foundation, 2004
His recent publications highlight advances in synthetic immunology, cancer exosome biology, and stem cell-derived islet applications. Collaborations include work on real-time microRNA monitoring in organoids and modeling T1D immune pathogenesis.
Dr. Hebrok’s lab contributes to understanding pancreatic development and leveraging stem cell technologies for diabetes therapy and cancer prevention.
